Raloxifene analog LY 117018 effects on central and peripheral β-endorphin

References

• MacGregor J I, Tonetti D A, Jordan V C. The complexity of selective estrogen receptor modulators: the design of a postmenopausal prevention maintenance therapy. Estrogens and Antiestrogens, R Lindsay, DW Dempster, VC Jordan. Lippincott-Raven Publishers, Philadelphia 1997; 261–77
   Google Scholar
• Paech K, Webb P, Kuiper GJM, et al. Differential ligand activation of estrogen receptor ERα and ERβ at AP1 sites. Science 1997; 277: 1508–10
   PubMed Web of Science ®Google Scholar
• Barkhem T, Carlsson B, Nilsson Y, et al. Differential response of ERα and ERβ to partial estrogen agonists/antagonists. Mol Pharmacol 1998; 54: 105–12
   PubMed Web of Science ®Google Scholar
• Laflamme N, Nappi R E, Drolet G, et al. Expression and neuropeptidergic characterization of estrogen receptors (ERα and ERβ) throughout the rat brain: anatomical evidence of distinct roles of each subtype. J Neurobiol 1998; 36: 357–78
   PubMedGoogle Scholar
• Shughrue P J, Lane M V, Merchenthaler I. Regulation of progesterone receptor messenger ribonucleic acid in the rat medial preoptic nucleus by estrogenic and anti-estrogenic compounds: an in situ hybridization study. Endocrinology 1997; 138: 5476–84
   PubMed Web of Science ®Google Scholar
• Shughrue P J, Komm B, Merchenthaler I. The distribution of estrogen receptor-beta mRNA in the rat hypothalamus. Steroids 1996; 61: 678–81
   PubMed Web of Science ®Google Scholar
• Hamm J T, Tormey D C, Kohler P C, et al. Phase I study of toremifene in patients wth advanced cancer. J Clin Oncol 1991; 9: 2036–41
   PubMed Web of Science ®Google Scholar
• Szamel I, Hindy I, Vincze B, et al. Influence of toremifene on the endocrine regulation in breast cancer patients. Eur J Cancer 1994; 30: 154–8
   Google Scholar
• Ortmann O, Emons G, Knuppen R, et al. Inhibitory actions of keoxifene on luteinizing hormone secretion in pituitary gonadotrophs. Endocrinology 1988; 123: 962–8
   PubMedGoogle Scholar
• Clemens J A, Bennett D R, Black L J, et al. Effects of a new anti-estrogen, Keoxifene LY156758, on growth of carcinogen induced mammary tumors and on LH and prolactin levels. 1983; 2869–75, Life Sci
   Google Scholar
• Gray J M, Ziemian L. Anti-estrogen binding sites in brain and pituitary of ovariectomized rats. Brain Res 1992; 578: 55–60
   PubMedGoogle Scholar
• Petersen S L, Barraclough C A. Suppression of spontaneous LH surges in estrogen treated ovariectomized rats by microimplants of anti-estrogens into the preoptic brain. Brain Res 1989; 484: 279–89
   PubMedGoogle Scholar
• Meisel R L, Dohanich G P, McEwen B S, et al. Antagonism of sexual behaviour in female rats by ventromedial hypothalamic implants of anti-estrogen. Neuroendocrinology 1987; 45: 201–7
   PubMedGoogle Scholar
• Early Breast Cancer Trials Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy. Lancet 1992; 339: 71–85
   PubMedGoogle Scholar
• Merchenthaler I, Funkhouser J M, Carver J M, et al. The effect of estrogens and anti-estrogens in a rat model for hot flush. Maturitas 1998; 30: 307–16
   PubMed Web of Science ®Google Scholar
• Nilsen J, Mor G, Naftolin F. Raloxifene induces neurite outgrowth in estrogen receptor positive PC12 cells. Menopause 1998; 5: 211–16
   PubMed Web of Science ®Google Scholar
• Petraglia F, Panerai A E, Rivier C, . Opioid control of gonadotropin secretion. The Brain and Female Reproductive Function, AR Genazzani, U Montemagno, C Nappi, et al. Parthenon Publishing, CarnforthUK 1987; 65–71
   Google Scholar
• Piva F, Limonta P, Maggi R, . Dual effects of the opioids in the control of gonadotropin secretion. Opiod Modulation of Endocrine Function, G Delitala, M Motta, M Serio, et al. Raven Press, New York 1984; 155–9
   Google Scholar
• Locatelli V, Petraglia F. Gonadal steroid modulation of brain and pituitary β-endorphin. Pituitary Hyperfunction: Physiopathology and Clinical Aspects, F Camanni, EE Muller. Raven Press, New York 1984; 35–40
   Google Scholar
• Jirikowski G F, Merchenthaler I, Rieger G E, et al. Estradiol target sites immunoreactive for β-endorphin in the arcuate nucleus of rat and mouse hypothalamus. Neurosci Lett 1986; 65: 121–5
   PubMed Web of Science ®Google Scholar
• Genazzani A R, Petraglia F, Mercuri N, et al. Effects of steroid hormones and antihormones on hypothalamic β-endorphin concentrations in intact and castrated female rats. J Endocrinol Invest 1990; 13: 91–6
   PubMed Web of Science ®Google Scholar
• Petraglia F, Penalva A, Locatelli V, et al. Effect of gonadectomy and gonadal steroid replacement on pituitary and plasma β-endorphin levels in rats. Endocrinology 1982; 111: 1224–9
   PubMed Web of Science ®Google Scholar
• Bradford M. A rapid and sensitive method for quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Annal Biochem 1976; 72: 248–59
   PubMed Web of Science ®Google Scholar
• Speroff L, Glass R H, Kase N H. Clinical Gynecological Endocrinology and Infertility 5th edn. Williams & Wilkins, Baltimore, Maryland
   Google Scholar
• Petraglia F, Locatelli V, Facchinetti F, et al. Oestrus cycle-related LH responsiveness to naloxone: effect of high oestrogen levels on the activity of opioid receptors. J Endocrinol 1986; 108: 89–94
   PubMedGoogle Scholar
• Barden N, Merand Y, Rouleau D, et al. Changes in the β-endorphin content of discrete hypothalamic nuclei during the estrous cycle of the rat. Brain Res 1981; 204: 441–5
   PubMedGoogle Scholar
• Knuth U A, Sikand G S, Casanueva F F, et al. Changes in β-endorphin content in discrete areas of the hypothalamus throughout proestrus and diestrus of the rat. Life Sci 1983; 33: 1443–50
   PubMedGoogle Scholar
• Genazzani A R, Petraglia F, Facchinetti F, et al. Increase of pro-opiomelanocortin related peptides during subjective menopausal flushes. Am J Obstet Gynecol 1984; 149: 775–9
   PubMed Web of Science ®Google Scholar
• Linghtman S L, Jacobs H S, Maguire A K. Climacteric flushing: clinical and endocrine response to infusion of naloxone. Br J Obslet Gynecol 1981; 88: 919–24
   PubMedGoogle Scholar
• Stomati M, Bersi C, Rubino S, et al. Neuroendocrine effects of different oestradiol-progestin regimens in postmenopausal women. Maturitas 1997; 28: 127–35
   PubMed Web of Science ®Google Scholar
• Genazzani A R, Petraglia F, Facchinetti F, . Effect of sex steroids on peripheral and pituitary endorphins. Endorphins, Neuroregulators and Behaviour in Human Reproduction, P Pancheri, L Zichella, P Falaschi, et al. Excerpta Medica. 1984; 146–52
   Google Scholar
• Genazzani A R, Trentini G P, Petraglia F, et al. Estrogens modulate the circadian rhythm of hypothalamic β-endorphin contents in female rats. Neuroendocrinology 1990; 52: 221–4
   PubMed Web of Science ®Google Scholar
• Genazzani A R, Petraglia F, Bergamaschi M, et al. Progesterone and progestins modulate β-endorphin concentrations in the hypothalamus and in pituitary of castrated female rats. Gynecol Endocrinol 1987; 1: 61–9
   PubMedGoogle Scholar
• Genazzani A R, Petraglia F, Bergamaschi M, . Progesterone and progestins modulate hypothalamic and pituitary β-endorphin. Female Contraception, B Runnebaum, T Rabe, L Kiesel, et al. Springer-Verlag, Heidelberg, Berlin 1988; 167–72
   Google Scholar
• Genazzani A R, Petraglia F, Facchinetti F, et al. Effects of Org OD 14 on pituitary and peripheral β-endorphin in castrated rats and postmenopausal women. Maturitas 1987; 1(Suppl)35–48
   PubMedGoogle Scholar
• Jones C D, Jevnikar M G, Pick A J, et al. Anti-estrogens. Structure-activity studies in a series of 3-aroyl-2-arylbenzolbthiophene derivatives leading to LY 156758, a remarkably effective estrogen antagonist with only minimal intrinsic estrogenicity. J Med Chem 1984; 27: 1057–66
   PubMed Web of Science ®Google Scholar